Capacity idea One side is the price war can not stop
2 December, 2014 at 2:05 am in Auto
Location : Capacity idea One side is the price war can not stopSend Inquiry
Capacity idea One side is the price war can not stop, the other side is the capacity utilization NIBP Cuff industry downturn accelerated change in the situation.
Report this reporter from a domestic flagship concept infusion pre-IPO disclosure of listed companies recently seen, from 2011 to 2013, the company glass bottle capacity utilization fell to 56.86% from 108.31%, non-PVC soft bag capacity utilization rate slipped to 87.50 percent from 98.87 percent. After the IPO, will invest 200 million annual freeze-dried powder production line and an annual output of 150 million bags of non-PVC soft bag infusion production line. Some experts said that "China's pharmaceutical industry in general overcapacity and Temperature Probe optimize capacity utilization is now the most urgent." Moreover, ECG Cable China's annual production of infusion preparations, except IBP Cable for clinical, some also for export, but also for animals, there are some products due to large volume infusion, considerable weight, transportation difficulties, coupled with post-production inspection cycle for several days, so there are a lot of products in circulation. Preparation to the hospital, not only for the infusion, but also for flushing surgery, wound dressing, hemodialysis, peritoneal dialysis, the amount is large, hospitals also have stock, this is the picture of the whole infusion capacity. Data released by the reporter noted Columbine medicine: 2013 annual SpO2 Sensor sales reached 3.984 billion infusion plates bottle bag, an increase of 8.15%, the production capacity Electrosurgical pencil of 4.147 billion infusion bottle bag, an increase of 9.29%; inventory of 865 million bottles of the bag, an increase of 25.51%. Koren outstanding infusion through the project and development of new products combined with antibiotics, and strengthen the industry leading position; by a three-compartment bag layout, dual-chamber bag, infusion therapy, large-scale infusion and other products to achieve sustainable development. Overcapacity only appearance, in essence, a structural surplus, but in the long run, the infusion areas remain temptation. Jimin pharmaceutical claims currently has 13 non-PVC soft bag infusion production line with annual capacity of 140 million bags, and is still expanding. Nationally, the infusion of the production capacity of about 16 billion bottles of the bag about the overall demand of about 13 billion to 140 billion bottles bags. "Basic infusion market is large, the future will be increasingly concentrated pattern, through the new version of GMP, market competition, and other small and medium elimination of backward production capacity. Direct software and other new products, infusion therapy will become the mainstream." Li Xin said.